Research
-
How does sight loss affect quality of life in children and young people?
Developing age-appropriate tools for patient-led healthcare
CompletedJanuary 2013 - April 2018 -
Development of novel antimicrobial therapy for Acanthamoeba Keratitis
Researchers seek to develop novel HDPs with enhanced efficacy and safety to treat Acanthamoeba Keratitis (AK).
CompletedApril 2021 - May 2023 -
The effect of inflammation throughout the body on AMD
Could looking at what’s happening outside the retina in long-term illness shed light on a new approach to treating age-related macular degeneration?
CompletedOctober 2013 - September 2016 -
Making a vital component of gene therapy for retinitis pigmentosa that can be used in clinical trials
Improving on a treatment that works well in animals with a natural form of severe sight loss
CompletedOctober 2013 - September 2016 -
Can a moving target help to make the most of peripheral vision?
Exploring new ideas for visual aids to improve life for people with AMD
CompletedOctober 2013 - September 2016 -
Repairing the retina’s blood supply before sight-threatening damage occurs
Developing a better alternative to anti-VEGF drugs
CompletedDecember 2013 - February 2017 -
How do cell recycling, inflammation and support cell death link together in dry AMD?
Understanding more about a substance that might proect against wet AMD and also cause the dry form.
CompletedOctober 2013 - September 2016 -
Developing a safe 'designer drug' to correct the genetic faults behind inherited eye disorders
A clever approach to treatment that could potentially restore sight
CompletedDecember 2013 - December 2016 -
Can we repair ‘misfolding’ proteins in a common type of retinitis pigmentosa?
Looking for substances that can make the light-detecting pigment rhodopsin more stable.
CompletedOctober 2014 - September 2018